Rip Road Capital Partners LP increased its position in shares of SunOpta, Inc. (NASDAQ:STKL - Free Report) TSE: SOY by 213.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 500,814 shares of the company's stock after acquiring an additional 340,914 shares during the quarter. SunOpta comprises 2.7% of Rip Road Capital Partners LP's holdings, making the stock its 14th biggest position. Rip Road Capital Partners LP owned 0.43% of SunOpta worth $2,434,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of the stock. Bayesian Capital Management LP increased its stake in SunOpta by 15.2% during the 4th quarter. Bayesian Capital Management LP now owns 11,536 shares of the company's stock valued at $89,000 after purchasing an additional 1,523 shares in the last quarter. EP Wealth Advisors LLC increased its position in shares of SunOpta by 11.9% in the 1st quarter. EP Wealth Advisors LLC now owns 16,477 shares of the company's stock valued at $80,000 after acquiring an additional 1,747 shares during the period. XTX Topco Ltd increased its position in shares of SunOpta by 3.3% in the 1st quarter. XTX Topco Ltd now owns 72,636 shares of the company's stock valued at $353,000 after acquiring an additional 2,354 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of SunOpta by 4.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 56,001 shares of the company's stock valued at $272,000 after acquiring an additional 2,424 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of SunOpta by 4.7% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 91,055 shares of the company's stock valued at $701,000 after acquiring an additional 4,053 shares during the period. Institutional investors and hedge funds own 85.39% of the company's stock.
SunOpta Stock Performance
Shares of NASDAQ STKL traded down $0.05 during mid-day trading on Tuesday, hitting $6.42. The stock had a trading volume of 429,133 shares, compared to its average volume of 591,021. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.39 and a current ratio of 0.96. The company has a 50 day moving average of $6.22 and a two-hundred day moving average of $5.65. SunOpta, Inc. has a twelve month low of $3.64 and a twelve month high of $8.11. The firm has a market cap of $758.78 million, a PE ratio of -107.00 and a beta of 1.35.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last released its earnings results on Wednesday, August 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.02. The firm had revenue of $191.49 million for the quarter, compared to the consensus estimate of $185.36 million. SunOpta had a positive return on equity of 12.82% and a negative net margin of 0.66%. Research analysts predict that SunOpta, Inc. will post 0.13 EPS for the current fiscal year.
SunOpta Profile
(
Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Featured Stories

Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.